Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

被引：219
|
作者：
Jiang, WG
Martin, TA
Parr, C
Davies, G
Matsumoto, K
Nakamura, T
机构：
[1] Cardiff Univ, Walles Coll Med, Dept Surg, Metastasis & Angiogenesis Res Grp, Cardiff CF14 4XN, S Glam, Wales
[2] Osaka Univ, Grad Sch Med, Div Mol Regenerat Med, Course Adv Med, Suita, Osaka, Japan
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2005年 / 53卷 / 01期
关键词：
hepatocyte growth factor; HGF; cMET; cancer metastasis; angiogenesis; signal transduction; cancer therapies;
D O I：
10.1016/j.critrevonc.2004.09.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatocyte growth factor plays multiple roles in cancer, by acting as a motility and invasion stimulating factor, promoting metastasis and tumour growth. Furthermore, it acts as a powerful angiogenic factor. The pivotal role of this factor in cancer has indicated HGF as being a potential target in cancer therapies. The past few years have seen rapid progress in developing tools in targeting HGF, in the context of cancer therapies, including development of antagonists, small compounds, antibodies and genetic approaches. The current article discusses the potential value of HGF and its receptor as targets in cancer therapies, the current development in anti-HGF research, and the clinical value of HGF in prognosis and treatment. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：35 / 69
页数：35
相关论文
共 50 条
  • [31] The hepatocyte growth factor receptor, Met, in prostate cancer invasion and metastasis
    Knudsen, BS
    You, X
    Gmyrek, G
    Vaughan, ED
    Vande Woude, G
    LABORATORY INVESTIGATION, 2002, 82 (01) : 167A - 168A
  • [32] The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
    Cecchi, Fabiola
    Rabe, Daniel C.
    Bottaro, Donald P.
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (02) : 146 - 151
  • [33] Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
    Satoshi Katayama
    Victor M. Schuettfort
    Benjamin Pradere
    Keiichiro Mori
    Hadi Mostafaei
    Fahad Quhal
    Reza Sari Motlagh
    Ekaterina Laukhtina
    Nico C. Grossmann
    Abdulmajeed Aydh
    Pawel Rajwa
    Frederik König
    Pierre I. Karakiewicz
    Martin Haydter
    Marco Moschini
    Mohammad Abufaraj
    Yair Lotan
    Richard K. Lee
    Quoc-Dien Trinh
    Eva Compérat
    Jeremy Teoh
    Yasutomo Nasu
    Shahrokh F. Shariat
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3091 - 3102
  • [34] Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
    Katayama, Satoshi
    Schuettfort, Victor M.
    Pradere, Benjamin
    Mori, Keiichiro
    Mostafaei, Hadi
    Quhal, Fahad
    Motlagh, Reza Sari
    Laukhtina, Ekaterina
    Grossmann, Nico C.
    Aydh, Abdulmajeed
    Rajwa, Pawel
    Koenig, Frederik
    Karakiewicz, Pierre, I
    Haydter, Martin
    Moschini, Marco
    Abufaraj, Mohammad
    Lotan, Yair
    Lee, Richard K.
    Quoc-Dien Trinh
    Comperat, Eva
    Teoh, Jeremy
    Nasu, Yasutomo
    Shariat, Shahrokh F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3091 - 3102
  • [35] Expression of hepatocyte growth factor and its receptor in the regenerating rat pancreas.
    Stubbs, M
    Reitz, P
    Taneja, M
    BonnerWeir, S
    DIABETES, 1997, 46 : 1099 - 1099
  • [36] Inhibition of MET Receptor Tyrosine Kinase and Its Ligand Hepatocyte Growth Factor
    Sadiq, Ahad A.
    Geynisman, Daniel M.
    Salgia, Ravi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : S1810 - S1811
  • [37] Pleiotropic actions of the hepatocyte growth factor and its tyrosine kinase receptor Met
    Tulasne, D
    Paumelle, R
    Fafeur, V
    M S-MEDECINE SCIENCES, 2001, 17 (02): : 232 - 237
  • [38] Hepatocyte growth factor and its receptor c-met in multiple myeloma
    Borset, M
    HjorthHansen, H
    Seidel, C
    Sundan, A
    Waage, A
    BLOOD, 1996, 88 (10) : 3998 - 4004
  • [39] Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells
    Parr, C
    Jiang, WG
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (04) : 857 - 863
  • [40] CLINICAL SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR (HGF) AND ITS RECEPTOR CMET LEVELS IN COLORECTAL CANCER PATIENTS
    Karabulut, Mehmet
    Alis, Halil
    Gunaldi, Meral
    Afsar, Cigdem Usul
    Karabulut, Senem
    Kones, Osman
    Seyit, Hakan
    Serilmez, Murat
    Aykan, Nuri Faruk
    ACTA MEDICA MEDITERRANEA, 2016, 32 (01): : 179 - 187
12345